首页> 外文期刊>Archives of disease in childhood >Management of severe hypertension in the newborn
【24h】

Management of severe hypertension in the newborn

机译:新生儿严重高血压管理

获取原文
获取原文并翻译 | 示例
       

摘要

Blood pressure is considered a vital sign, as values too low or too high can be related with serious morbidity and mortality. In neonates, normal blood pressure values undergo rapid changes, especially in premature infants, making the recognition of abnormal blood pressures more challenging. Severe hypertension can occur in neonates and infants and is a medical emergency, often manifesting with congestive heart failure or other life-threatening complications. The cause or risk factors for the hypertension can usually be identified and may guide management. Most classes of antihypertensive medications have been used in the neonatal population. For severe hypertension, intravenous short-acting medications are preferred for a controlled reduction of blood pressure. In this article, we focus on identification, aetiology and management of severe hypertension in the newborn.
机译:血压被认为是一个重要的标志,因为值过低或过高的值可能与严重的发病率和死亡率有关。 在新生儿中,常规血压值经过快速变化,特别是在早产儿,使得识别异常血压更具挑战性。 严重的高血压可以发生在新生儿和婴儿中,并且是一种医疗紧急情况,往往表现出充血性心力衰竭或其他危及生命的并发症。 通常可以识别高血压的原因或风险因素,并可引导管理。 大多数阶段的抗高血压药物已用于新生儿人群中。 对于严重的高血压,静脉内短作用药物优选用于减少血压。 在本文中,我们专注于新生儿中严重高血压的鉴定,病态和管理。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号